Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis.
| Authors | Rosa Andres-Ejarque, Hira Bahadur Ale, Katarzyna Grys, Isabella Tosi, Shane Solanky, Chrysanthi Ainali, Zeynep Catak, Hemawtee Sreeneebus, Jake Saklatvala, Nick Dand, Emanuele de Rinaldis, Anna Chapman, Frank O Nestle, Michael R Barnes, Richard B Warren, Nick J Reynolds, Christopher E M Griffiths, Jonathan N Barker, Catherine H Smith, Paola Di Meglio, PSORT Consortium |
| Journal | Nature communications
(Nat Commun)
Vol. 12
Issue 1
Pg. 7358
(Dec 16 2021)
ISSN: 2041-1723 [Electronic] England |
| PMID | 34916493
(Publication Type: Published Erratum)
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|
